Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Grace Lim, MD, MS
With
University of Pittsburgh
This study is a randomized control trial with the following arms: 1) active device; 2) placebo device; 3) non-intervention (active control). The devices will be placed while women are still feeling pain relief from labor epidural analgesia (after delivering vaginally) or from spinal or epidural anesthesia (after delivering by cesarean). By applying the devices while women are still relatively pain-free, a preventative/pre-emptive approach to pain management in women at risk for severe postpartum pain is taken. The study will enroll women with and without OUD and follow them for five days postpartum.
Age
18–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Pregnant
Third trimester
Cesarean delivery under neuraxial anesthesia
Healthy, clean skin
18 years or older
You may not be if
Not fluent in English (surveys are validated in English language), unable to participate in informed consent discussions, or unable to give informed consent for any reason
Unable to participate fully in all study procedures for any reason
Cesarean delivery under general anesthesia
History of hemophilia
Pacemakers or implantable electronic devices
History of psoriasis
Clareo Health | BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control